BridgeMD
New treatment option for Dry Needling Technique
Official title Effects of Dry Needling on Latent Myofascial Trigger Points of the Extensor Digitorum Communis
ClinicalTrials.gov ID: NCT07672093
What this study is testing
- What it's testing
- This randomized single-blind clinical trial aims to compare the effects of different dry needling and electrical dry needling techniques applied to latent myofascial trigger points in the extensor digitorum muscle of the dominant forearm in healthy adults. Participants will be randomly allocated to one of five groups: a control group, a Hong fast-in and fast-out dry needling group, a rotational dry needling group, a bipolar electrical dry needling group, or a monopolar electrical dry needling group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40. Healthy volunteers may be eligible.
You may be able to join if
- Adults aged 18 to 40 years.
- Healthy participants with a latent myofascial trigger point in the extensor digitorum muscle of the dominant forearm.
- No pathology affecting the upper limb where the intervention will be applied.
- No episode of pain in the upper limb during at least the previous two months.
- No contraindications to dry needling or electrical dry needling techniques.
You likely can't join if
- Needle phobia.
- Coagulation disorders.
- Pregnancy.
- Thyroid disorders.
- Altered skin integrity in the treatment area.
- Epilepsy.
See the full eligibility criteria
- Adults aged 18 to 40 years.
- Healthy participants with a latent myofascial trigger point in the extensor digitorum muscle of the dominant forearm.
- No pathology affecting the upper limb where the intervention will be applied.
- No episode of pain in the upper limb during at least the previous two months.
- No contraindications to dry needling or electrical dry needling techniques.
- Voluntary signature of the informed consent form.
- Willingness to follow the protocol proposed by the research team.
- Needle phobia.
- Coagulation disorders.
- Pregnancy.
- Thyroid disorders.
- Altered skin integrity in the treatment area.
- Epilepsy.
- Local or systemic infection.
- Diagnosed neurological disorders affecting pain perception or neuromuscular function in the region of interest, such as multiple sclerosis or peripheral neuropathies.
- Generalized chronic pain conditions, such as fibromyalgia.
- Weekly use of analgesic medication, including anti-inflammatory drugs, opioids, or other pain-relieving medication.
The study team makes the final eligibility decision.
Where it's taking place
- Reus, Tarragona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Reus, Tarragona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.